The impact of allergic rhinitis and its treatment on the pharmacokinetics of nasally administered fentanyl

Michael Perelman, A.N. Fisher, Alan Smith, Alastair D. Knight

International Journal of Clinical Pharmacology and Therapeutics · 2013 · 16 citations · 0 references

Abstract

Patients treated with FPNS will be unaffected by the development of allergic rhinitis; but, if oxymetazoline is prescribed, the patient would benefit from added supervision when oxymetazoline is started and stopped.